Intermittent Fasting Shows Promising Results for Type 2 Diabetes

[Rudy]

A recent study published in JAMA Network Open has revealed that intermittent fasting can significantly benefit people with Type 2 diabetes. The study compared the 5:2 fasting diet with two common diabetes medications, metformin and empagliflozin, and found that fasting provided greater metabolic benefits.

Key Findings:

Weight Loss and Blood Sugar Control: Over 16 weeks, participants on the 5:2 diet lost an average of 21 pounds, compared to 12 pounds with metformin and 12.8 pounds with empagliflozin. The fasting group also saw a more significant reduction in HbA1c levels, a measure of blood sugar.
5:2 Diet Explained: The 5:2 diet involves eating normally for five days and consuming only 500-600 calories on two fasting days. This diet gained popularity through a BBC documentary and Michael Mosley's book "The Fast Diet."
Sustained Improvements: After eight weeks post-study, most fasting participants maintained their improved blood sugar levels, suggesting long-term benefits.
Study Details:

Conducted in China, involving over 330 newly diagnosed overweight and obese Type 2 diabetes patients.
Participants were split into three groups: one taking metformin, another empagliflozin, and the third following the 5:2 diet with meal replacements.
On fasting days, participants consumed minimal food and a low-calorie meal-replacement drink.
Expert Insights:

The study effectively combined intermittent fasting with meal replacements, both known to aid in weight loss and blood sugar control.
Despite initial impressive results, there is a concern about long-term adherence to the 5:2 diet.
Cautions and Recommendations:

About 6% of participants on the fasting diet experienced low blood sugar symptoms, highlighting the importance of medical supervision.
People interested in trying the 5:2 diet should consult their doctor, especially considering the potential risks.
Intermittent fasting, particularly the 5:2 diet, offers a promising alternative for managing Type 2 diabetes, but long-term studies and medical guidance are crucial for safe and sustained results.

Washingtonpost.com